- Report
- March 2025
- 140 Pages
Global
From €4282EUR$4,850USD£3,720GBP
- Report
- July 2023
- 294 Pages
Global
From €3178EUR$3,600USD£2,761GBP
- Report
- July 2023
- 139 Pages
Asia Pacific
From €1324EUR$1,500USD£1,150GBP
- Report
- March 2025
- 150 Pages
Global
From €4282EUR$4,850USD£3,720GBP
- Report
- October 2025
- 84 Pages
Saudi Arabia
From €4282EUR$4,850USD£3,720GBP
- Report
- October 2025
- 98 Pages
Saudi Arabia
From €4282EUR$4,850USD£3,720GBP
- Report
- April 2025
- 135 Pages
Global
From €4282EUR$4,850USD£3,720GBP
- Report
- March 2025
- 134 Pages
Global
From €4282EUR$4,850USD£3,720GBP
- Report
- February 2025
- 155 Pages
Global
From €4282EUR$4,850USD£3,720GBP
- Report
- September 2022
- 113 Pages
Global
From €1766EUR$2,000USD£1,534GBP
- Report
- May 2023
- 116 Pages
Global
From €3500EUR$4,247USD£3,147GBP
- Report
- November 2024
- 90 Pages
Global
From €3500EUR$4,247USD£3,147GBP
- Book
- April 2024
North America
The Antiparasitic Agent market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs used to treat parasitic infections. Antiparasitic Agents are used to treat a variety of parasitic infections, including malaria, schistosomiasis, and leishmaniasis. These drugs are typically administered orally, intravenously, or topically, depending on the type of infection. Antiparasitic Agents are often used in combination with other drugs to ensure the most effective treatment.
The Antiparasitic Agent market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, and Novartis. Other companies, such as Johnson & Johnson, Bayer, and AstraZeneca, also offer Antiparasitic Agents. Show Less Read more
